Skip to main content

Table 2 Summary of findings

From: Effects, barriers and facilitators in predischarge home assessments to improve the transition of care from the inpatient care to home in adult patients: an integrative review

PDHA compared with usual care for adults with any diagnosis at all
Patients or population: adults with any diagnosis at all (except mental disorders only)
Setting: acute / sub-acute hospital care or rehabilitation unit
Intervention: predischarge home assessment
Comparison: usual care
Outcomes SMD or MD or RR, [95% CI], I2, p Number of participants (number of studies) GRADE Comments
IADL/ADL. Various scales. Including studies with NEADL, NEADL (60), SMAF, SWED-QUAL Subscale Physical function. Higher score indicates better function. Mean duration of follow-up: 8 months (range 1–12 months) SMD − 0.17 [− 0.76, 0.42], I2 = 90%
p = 0.58
655 (7) OOO very lowa  
IADL/ADL. NEADL Score 0–22 points. Higher score indicates better results. Mean duration of follow-up: 2.8 months (range 1–6 months) MD − 0.35 [− 1.31, 0.61], I2 = 79%
p = 0.34
510 (5) OOO very lowc  
Quality of life. Various scales: EQ-5D overall score, EQ-5D subscale VAS, SWED-QUAL subscale general health perception. Higher score indicates better health status. Mean duration of follow-up: 2.6 months (range 1–6 months) SMD 0.06 [− 030, 0.42] I2 = 42%
p = 0.74
263 (5) OOO lowc  
Quality of life. EQ-5D overall score 0–1. Higher score indicates better health status. Mean duration of follow-up: 2.6 months (range 1–6 months) MD 0.03 [− 0.08, 0.15], I2 = 0%
p = 0.56
186 (3) OO lowb  
Mobility. Various scales: Tinetti (scale 4–24) and RMI (0–15). Higher scores indicate better mobility. Mean duration of follow-up: 2 months (range 1–3 months) SMD 1.24 [‘-0.69, 3.17], I2 = 78%
p = 0.21
26 (2) OOO very lowb  
Fear of falling. FES-I Score 10–100. Higher scores indicate more confidence. Mean duration of follow-up: 3.3 months (range 1–6 months) MD − 4.01 [− 10.4, 2.05], I2 = 51%
p = 0.19
85 (3) OOO very lowc Fixed effect model: (MD − 4.74 [− 8.30, − 1.18] I2 = 51%, p = 0.009
Risk of falling Mean duration of follow-up: 9.2 months (range 1–12 months) RR 0.88 [0.70, 1.09], I2 = 0%
p = 0.25
501 (5) Od moderate  
Risk of readmission: Mean duration of follow-up: 5 months (range 1–12 months) RR 1.09 [0.64, 1.87], I2 = 43%
p = 0.74
590 (5) Od moderate  
Adverse effects of intervention: Zero adverse events in both groups were reported in one study. 59 (1)   
  1. a downgraded due to unblinded personnel and participants, inconsistency and imprecision of results
  2. b downgraded due to inconsistency and high imprecision of results
  3. c downgraded due to downgrade because of unblinded participants and personnel, and imprecision of results
  4. d downgraded due to imprecision of results; FE Fixed effect model, RE Random effects model